Moskvin Sergej Vladimirovich,Москвин Сергей Владимирович,Gejnits Aleksandr Vladimirovich,Гейниц Александр Владимирович,Askhadulin Evgenij Valerevich,Асхадулин Евгений Валерьевич
申请号：
RU2015151460/14
公开号：
RU0002604399C1
申请日:
2015.12.01
申请国别(地区):
RU
年份:
2016
代理人:
摘要：
FIELD: medicine.SUBSTANCE: invention reates to medicine, namely to surgery, and can be used for treating patients with trophic ulcers (TU). With underlying conventional pharmacotherapy in I phase of wound process hydrophilic antibacterial ointment and bandages with antiseptic solutions are used. In II and III phases of wound process kuriosine preparation is used. Light exposure is performed in one session on 1-4 damage areas for 2 minutes per one region. Mode is pulse one. Light pulse length is 100-130 ns. Wave length is 635 nm. Matrix emitter of 8 laser diodes with surface area of 8 cm2 is used. Exposure is made from distance of 7 cm. Pulse power is 40 W. ILBI is made with low-intensity laser radiation in continuous mode at wave length of 365-405 nm (UV spectrum) and 520-525 nm (green spectrum) alternately during 12 daily sessions according to schedule: 1 session - 365-405 nm, power 1-2 mW, exposure 2 minutes 2 session - 520-525 nm, power 1-2 mW, exposure 5 minutes 3 session - 365-405 nm, power 1-2 mW, exposure 2 minutes 4 session - 520-525 nm, power 1-2 mW, exposure 5 minutes 5 session - 365-405 nm, power 1-2 mW, exposure 2 minutes 6 session - 520-525 nm, power 1-2 mW, exposure 5 minutes 7 session - 365-405 nm, power 1-2 mW, exposure 2 minutes 8 session - 520-525 nm, power 1-2 mW, exposure 5 minutes 9 session - 365-405 nm, power 1-2 mW, exposure 2 minutes 10 session - 520-525 nm, power 1-2 mW, exposure 5 minutes 11 session - 365-405 nm, power 1-2 mW, exposure 2 minutes 12 session - 520-525 nm, power 1-2 mW, exposure 5 minutes.EFFECT: method provides effect on different links of pathogenesis, which leads to reducing length of healing ulcers, generation of stable physiological reaction of adaptation, preventing development of recurrent TU, thereby increasing effectiveness of treating patients with TU.1 cl, 2 tblИзобретение относится к медицине, а именно к хирургии, и может быть использовано для лечения больных трофическими язвами (ТЯ). На фоне стандартной фармакотер
